These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1680257)

  • 61. Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients.
    Plouin PF
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():49-53; discussion 53-4. PubMed ID: 2575176
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Labetalol in the treatment of angina pectoris.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):166-74. PubMed ID: 2881899
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Alpha-adrenoceptor antagonist (blocker)].
    Shigetomi S
    Nihon Rinsho; 1997 Aug; 55(8):2055-60. PubMed ID: 9284423
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alpha 2-adrenergic receptors and calcium: alpha 2-receptor blockade in vascular smooth muscle as an approach to the treatment of hypertension.
    Lee JY; DeBernardis JF
    Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):213-25. PubMed ID: 1972206
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The mechanism of the action of Minipress. Examinations in hypertension.
    Török E; Bíró V; Podmaniczky M
    Ther Hung; 1989; 37(2):90-8. PubMed ID: 2573964
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical use of calcium antagonists in hypertension: update 1986.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S29-35. PubMed ID: 2455135
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effect of alpha inhibitors on risk cofactors in patients with hypertension].
    Plouin P
    Ann Cardiol Angeiol (Paris); 1989 Dec; 38(9 Pt 2):577-9; discussion 580. PubMed ID: 2576348
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Controversies in the treatment of arterial hypertension: other drugs as the first step (calcium antagonists, ACE inhibitors and alpha-blockers)].
    Castro Beiras A; Muñiz J; Juane R
    Rev Esp Cardiol; 1995; 48 Suppl 4():72-80. PubMed ID: 7494933
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance.
    Cubeddu LX
    Am Heart J; 1988 Jul; 116(1 Pt 1):133-62. PubMed ID: 2899387
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism.
    Nash DT
    Clin Cardiol; 1990 Nov; 13(11):764-72. PubMed ID: 1980236
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alpha 1 blockers. Safe, effective treatment for hypertension.
    Itskovitz HD
    Postgrad Med; 1991 Jun; 89(8):89-92, 95-8, 103-6, passim. PubMed ID: 1674822
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more?
    Ligueros M; Unwin R; Wilkins M
    Clin Auton Res; 1991 Sep; 1(3):251-8. PubMed ID: 1687998
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The place of alpha blockers in the treatment of hypertension.
    Reid JL
    Clin Exp Hypertens; 1993 Nov; 15(6):1291-7. PubMed ID: 7903577
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Overview of alpha 1-adrenoceptor antagonism and recent advances in hypertensive therapy.
    Veelken R; Schmieder RE
    Am J Hypertens; 1996 Nov; 9(11):139S-149S. PubMed ID: 8931846
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [New findings on the use of specific alpha-1 adrenergic blockers in the treatment of high blood pressure].
    Horký K
    Vnitr Lek; 1991 Jun; 37(6):604-11. PubMed ID: 1680257
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hypertension and CHD risk: whither alpha-1 blockers?
    Pandit RB
    Indian Heart J; 1996; 48(3):265-71. PubMed ID: 8755013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review.
    Weidinger G
    Arzneimittelforschung; 1995 Nov; 45(11):1166-71. PubMed ID: 8929232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.